ReiThera: “Stop Corte dei Conti puts vaccine development at risk”

The “unexpected interruption” of funding for testing the ‘Italian’ anti Covid vaccine by ReiThera “risks compromising the process of making the vaccine and harming society itself”. This was stated by the Castel Romano company, commenting on the reasons published yesterday by the Court of Auditors. Read also The reasons “concern technical aspects that are not within the competence of the company. The company has limited itself to carrying out what is indicated from time to time in this very long path” underlines ReiThera in a note.